FDA approves Lu-177 PSMA-617 for prostate cancer treatment
March 23, 2022 -- The U.S. Food and Drug Administration (FDA) has approved lutetium-177 (Lu-177) prostate-specific membrane antigen radioligand therapy for the treatment of patients with metastatic prostate cancer. Read More
NaF-PET reveals aortic wall injuries
March 22, 2022 -- PET imaging with F-18 sodium fluoride (NaF) can detect activity related to tears in the outer wall of the aorta and could help manage patients with acute aortic syndrome, according to a study published March 16 in JACC: Cardiovascular Imaging. Read More
Voxel-based technique improves tau PET for Alzheimer's disease
March 21, 2022 -- A new technique that tracks individual voxels on tau PET scans in patients with Alzheimer's disease appears effective for detecting early signs of the disease, according to a study published March 17 in the Journal of Nuclear Medicine. Read More
Tc-99m SPECT/CT imaging detects COVID-19
March 18, 2022 -- Iranian nuclear medicine physicians diagnosed COVID-19 in an asymptomatic patient undergoing technetium-99m (Tc-99m) SPECT/CT imaging for prostate cancer, according to a March 15 report in the Egyptian Journal of Radiology and Nuclear Medicine. Read More
Immuno-PET reveals persistent HIV infection
March 15, 2022 -- A new immuno-PET imaging method may offer a novel approach to detecting low levels of HIV in patients undergoing antiretroviral therapy (ART), according to a study published March 9 in Nature Communications. Read More
PET/CT predicts treatment outcomes in myeloma patients
March 9, 2022 -- PET/CT can help predict which patients have better chances of survival after starting treatment for multiple myeloma, according to a study published March 3 in Blood Advances. Read More
CT radiomics predicts rectal cancer treatment response
March 8, 2022 -- Radiomics analysis of pretreatment CT exams can help to predict response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer, according to research presented at last week's ECR 2022 Overture. Read More
ECR: Hypmed project develops affordable PET/MRI for breast scans
March 4, 2022 -- A European research project called Hypmed is developing a more affordable version of PET/MRI technology to better diagnose breast cancer, according to researchers who presented March 3 at the ECR Overture congress. Read More
Spinal fluid tests may aid PET scans of Alzheimer's disease
March 4, 2022 -- Spinal fluid and blood tests may help recruit patients for PET studies of new Alzheimer's disease treatments, according to research published February 28 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Read More
Tau PET may predict psychosis in Alzheimer's disease
March 1, 2022 -- PET imaging has shown that Alzheimer's disease patients who have increases in brain tau pathology are more likely over time to experience psychosis and rapid cognitive and functional decline, according to a study published February 26 in Translational Psychiatry. Read More